Table 4. Coverage by commercial a , b and investigational c , d HPV vaccines of ≥1 HPV infecting type(s), by gender identity of MSM subjects in Chiang Mai, Thailand, 2012–2013.
| No. of participant / Total cases (%) | Increased percentage coverage above 2-valent (95% CI) | Ratio to 2-valent (95% CI) | Statistic, p-value | |
|---|---|---|---|---|
| Gay Men, N(%) | ||||
| 2-valent | 33 / 85 (38.8) | Ref. | ||
| 4-valent | 45 / 85 (52.9) | +14.1 (5.5–22.7) | 1.4 (1.1–1.6) | χ2 (1) = 12.0, p = 0.0005 |
| 7-valent | 54 / 85 (63.5) | +24.7 (14.4–35.1) | 1.6 (1.3–2.0) | χ2 (1) = 21.0, p = 0.000 |
| 9-valent | 61 / 85 (71.8) | +32.9 (21.8–44.1) | 1.9 (1.5–2.3) | χ2 (1) = 28.0, p = 0.000 |
| Bisexual Men, N(%) | ||||
| 2-valent | 7 / 29 (24.1) | Ref. | ||
| 4-valent | 10 / 29 (34.5) | +10.3 (-4.2–24.9) | 1.4 (1.0–2.1) | χ2 (1) = 3.0, p = 0.083, NS |
| 7-valent | 8 / 29 (27.6) | +3.5 (-6.6–13.5) | 1.1 (0.9–1.5) | χ2 (1) = 1.0, p = 0.317, NS |
| 9-valent | 11 / 29 (37.9) | +13.8 (-2.2–29.8) | 1.6 (1.0–2.5) | χ2 (1) = 4.0, p = 0.046 |
| Transgender Women, N(%) | ||||
| 2-valent | 30 / 83 (36.1) | Ref. | ||
| 4-valent | 40 / 83 (48.2) | +12.1 (3.8–20.3) | 1.3 (1.1–1.6) | χ2 (1) = 10.0, p = 0.002 |
| 7-valent | 49 / 83 (59.0) | +22.9 (12.7–33.1) | 1.6 (1.3–2.0) | χ2 (1) = 19.0, p = 0.000 |
| 9-valent | 54 / 83 (65.1) | +28.9 (18.0–39.9) | 1.8 (1.4–2.3) | χ2 (1) = 24.0, p = 0.000 |
| All participant, N(%) | ||||
| 2-valent | 70 / 197 (35.5) | Ref. | ||
| 4-valent | 95 / 197 (48.2) | +12.7 (7.5–17.8) | 1.4 (1.2–1.5) | χ2 (1) = 25.0, p = 0.000 |
| 7-valent | 111 / 197 (56.4) | +20.8 (14.6–27.0) | 1.6 (1.4–1.8) | χ2 (1) = 41.0, p = 0.000 |
| 9-valent | 126 / 197 (64.0) | +28.4 (21.6–35.2) | 1.8 (1.5–2.1) | χ2 (1) = 56.0, p = 0.000 |
a 2–valent coverage: number infected with ≥1 HPV type(s) 16 and/or 18
b 4–valent coverage: number infected with ≥1 HPV type(s) 16, 18, 6, and/or 11
c 7–valent coverage: number infected with ≥1 HPV type(s) 16, 18, 31, 33, 45, 52, and/or 58
d 9–valent coverage: number infected with ≥1 HPV type(s) 16, 18, 31, 33, 45, 52, 58, 6, and/or 58).